Expression of long non-coding RNA MEG3 and its relationship with the prognosis of human gastric cancer
10.3969/j.issn.1000-8179.2016.15.565
- VernacularTitle:长链非编码RNAMEG3在胃癌中的表达及其与预后的关系
- Author:
Feifei MENG
;
Junli SI
;
Lu LIU
;
Jingyuan CUI
;
Yuqin QI
;
Mei LV
- Publication Type:Journal Article
- Keywords:
gastric cancer;
long non-coding RNA;
maternally expressed gene 3;
real-time fluorescent quantitative reverse transcriptase PCR
- From:
Chinese Journal of Clinical Oncology
2016;43(15):659-662
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the expression of maternally expressed gene 3 (MEG3), a long non-coding RNA gene, in gastric can-cer tissues;determine the relationship of MEG3 with the prognosis of gastric cancer;and explore the relationship between MEG3 and apoptosis-associated protein P53 as well as murine double minute 2 (MDM2). Methods:Fifty-five consecutive patients with gastric cancer admitted to Qingdao Municipal Hospital for surgical treatment from September 2012 to June 2013 were included in this study. Gastric cancer and paired normal tissues were collected. The expression of MEG3 was tested through real-time quantitative poly-merase chain reaction (qRT-PCR). Western blot analysis was used to detect the expression of P53 and MDM2 in gastric cancer and eval-uate their correlations with MEG3. Results:The expression of MEG3 decreased in cancer tissues (7.98±0.19) relative to the correspond-ing normal tissues (9.47±0.18) (P<0.05). P53 and MDM2 showed negative relationships in the gastric cancer and normal tissues. A posi-tive relationship was found between P53 and MEG3 (r=0.591, P<0.05), whereas a negative relationship was found between MDM2 and MEG3 (r=?0.346, P<0.05). The median survival time was significantly prolonged in patients with high MEG3 expression compared with patients with low MEG3 expression. Conclusion:MEG3 exerts an inhibiting effect on the development of gastric cancer. MEG3, P53, and MDM2 may have important relationships in the biological mechanisms of gastric cancer development. Detecting the expression level of MEG3 may be useful for the prognosis of gastric cancer.
